Us Bancorp \De\ Harpoon Therapeutics, Inc. Transaction History

Us Bancorp \De\

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 10, 2021	SELL	$7.88 - $14.0 $1,906 - $3,388	-242 Reduced 73.11%	89 $1,000
Q2 2021 Aug 05, 2021	SELL	$13.81 - $23.25 $2,402 - $4,045	-174 Reduced 34.46%	331 $5,000
Q1 2021 Apr 28, 2021	SELL	$17.65 - $24.16 $21,180 - $28,992	-1,200 Reduced 70.38%	505 $11,000
Q4 2020 Feb 04, 2021	BUY	$12.83 - $17.84 $6,479 - $9,009	505 Added 42.08%	1,705 $28,000
Q3 2020 Nov 10, 2020	BUY	$11.01 - $18.52 $5,956 - $10,019	541 Added 82.09%	1,200 $20,000
Q2 2020 Aug 07, 2020	BUY	$11.11 - $24.72 $655 - $1,458	59 Added 9.83%	659 $11,000
Q1 2020 May 13, 2020	BUY	$10.74 - $16.32 $3,222 - $4,896	300 Added 100.0%	600 $7,000
Q3 2019 Nov 08, 2019	BUY	$10.93 - $17.47 $3,279 - $5,241	300 New	300 $4,000

353K

Ticker HARP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 33,106,800
Description
Harpoon Therapeutics, Inc., a clinical-stage immunotherapy company, engages in the development of a novel class of T cell engagers that harness the power of the body's immune system to treat patients suffering from cancer and other diseases in the United States. The company develops tri-specific T cell activating construct (TriTAC) product candi...

Get notified when there are updates to the investment portfolio of Us Bancorp \De\, based on Form 13F filings with the SEC.

Stay updated on Us Bancorp \De\ with notifications on news.